Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines

A novel coronavirus (CoV), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in late 2019 in Wuhan, China and has since spread as a global pandemic. Safe and effective vaccines are thus urgently needed to reduce the significant morbidity and mortality of Coronavirus Disease 2019...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambert, Paul-Henri, Ambrosino, Donna M., Andersen, Svein R., Baric, Ralph S., Black, Steven B., Chen, Robert T., Dekker, Cornelia L., Didierlaurent, Arnaud M., Graham, Barney S., Martin, Samantha D., Molrine, Deborah C., Perlman, Stanley, Picard-Fraser, Philip A., Pollard, Andrew J., Qin, Chuan, Subbarao, Kanta, Cramer, Jakob P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247514/
https://www.ncbi.nlm.nih.gov/pubmed/32507409
http://dx.doi.org/10.1016/j.vaccine.2020.05.064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247514/
https://www.ncbi.nlm.nih.gov/pubmed/32507409
http://dx.doi.org/10.1016/j.vaccine.2020.05.064

Ejemplares similares